Certolizumab Pegol Improves Patient-Reported Outcomes in Chronic Plaque Psoriasis Over 1 Year

Authors

Diamant Thaci
Alice B. Gottlieb, New York Medical CollegeFollow
Kristian Reich
Jerry Bagel
Luke Peterson
Oana Purcaru
Jolanta Weglowska

Author Type(s)

Faculty

Document Type

Abstract

Publication Date

6-2018

Journal Title

Acta Dermato-Venereologica

Department

Dermatology

Recommended Citation

Thaci, D., Gottlieb, A. B., Reich, K., Bagel, J., Peterson, L., Purcaru, O., & Weglowska, J. (2018). Certolizumab Pegol Improves Patient-Reported Outcomes in Chronic Plaque Psoriasis Over 1 Year. Acta Dermato-Venereologica, 98 (Suppl. 219), 57-58. Retrieved from https://touroscholar.touro.edu/nymc_fac_abstracts/320